Coronary artery aneurysms, insights from the international coronary artery aneurysm registry (CAAR).


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 27 09 2018
revised: 13 05 2019
accepted: 27 05 2019
pubmed: 6 8 2019
medline: 24 11 2020
entrez: 6 8 2019
Statut: ppublish

Résumé

Coronary Aneurysms are a focal dilatation of an artery segment >1.5-fold the normal size of adjacent segments. Although some series have suggested a prevalence of 0.3-12%, data are lacking. In addition, they are not mentioned in practice guidelines. Our aim was investigate its prevalence, management and long-term outcomes. The coronary artery aneurysm registry (CAAR) involved 32 hospitals across 9 countries in America and Europe. We reviewed 436,467 consecutive angiograms performed over the period 2004-2016. Finally, 1565 patients were recruited. Aneurysm global prevalence was 0.35%. Most patients were male (78.5%) with a mean age of 65 years and frequent cardiovascular risk factors. The main indication for angiogram was an acute coronary syndrome, 966 cases. The number of aneurisms was ≤2 per patient in 95.8% of the cases, mostly saccular, most frequently found in the left anterior descending and with numbers proportional with coronary stenosis. Aortopathies were related with more aneurysms too. Most patients received any revascularization procedure (69%), commonly percutaneous (53%). After a median follow-up of 37.2 months, 485 suffered a combined event (MACE) and 240 died. Without major differences comparing CABG vs PCI, MACE and death were more frequent in patients who received bare metal stents. Coronary artery aneurysms are not uncommon. Usually, they are associated with coronary stenosis and high cardiovascular risk. Antiplatelet therapy seems reasonable and a percutaneous approach is safe and effective.

Sections du résumé

BACKGROUND
Coronary Aneurysms are a focal dilatation of an artery segment >1.5-fold the normal size of adjacent segments. Although some series have suggested a prevalence of 0.3-12%, data are lacking. In addition, they are not mentioned in practice guidelines. Our aim was investigate its prevalence, management and long-term outcomes.
METHODS AND RESULTS
The coronary artery aneurysm registry (CAAR) involved 32 hospitals across 9 countries in America and Europe. We reviewed 436,467 consecutive angiograms performed over the period 2004-2016. Finally, 1565 patients were recruited. Aneurysm global prevalence was 0.35%. Most patients were male (78.5%) with a mean age of 65 years and frequent cardiovascular risk factors. The main indication for angiogram was an acute coronary syndrome, 966 cases. The number of aneurisms was ≤2 per patient in 95.8% of the cases, mostly saccular, most frequently found in the left anterior descending and with numbers proportional with coronary stenosis. Aortopathies were related with more aneurysms too. Most patients received any revascularization procedure (69%), commonly percutaneous (53%). After a median follow-up of 37.2 months, 485 suffered a combined event (MACE) and 240 died. Without major differences comparing CABG vs PCI, MACE and death were more frequent in patients who received bare metal stents.
CONCLUSIONS
Coronary artery aneurysms are not uncommon. Usually, they are associated with coronary stenosis and high cardiovascular risk. Antiplatelet therapy seems reasonable and a percutaneous approach is safe and effective.

Identifiants

pubmed: 31378382
pii: S0167-5273(18)35768-1
doi: 10.1016/j.ijcard.2019.05.067
pii:
doi:

Substances chimiques

Platelet Aggregation Inhibitors 0

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-55

Investigateurs

Piter Martínez Benítez (PM)
Antonio Gomez Menchero (AG)
Javier León Jimenez (JL)
José Francisco Díaz Fernandez (JFD)
Mohammed Makkiya (M)
Nurilign Bulcha (N)
Sarabjeet Suri (S)
Paol Rojas (P)
Tamara Garcia Camarero (TG)
Pablo Avanzas (P)
Cesar Morís (C)
Christoph Berndt (C)
Pedro Trujillo (P)
Gustavo Vignolo (G)
Rafael Mila (R)
Dario Buccheri (D)
Pedro Silva (P)
Giorgio Quadri (G)
Francesco Tomassini (F)
Cristina Rolfo (C)
Etelberto Hernández Hernández (EH)
José Antonio Baz Alonso (JAB)
Andrés Íñiguez Romo (AÍ)
Giulia Teresi (G)
Giuseppe Andolina (G)
Simone Calcagno (S)
Gonzalo Navarrete (G)
Fernando Rivero (F)
Javier Cuesta (J)
Daniella Benedetto (D)
Fatih Arslan (F)
Peter R Stella (PR)
Mª Isabel Barrionuevo Sánchez (MIB)
Rafael Gómez Vicente (RG)
Patricia Clares Montón (PC)
Dámaris Carballeira (D)
Geoffrey Yanes Bowden (GY)
Manuel Vargas Torres (MV)
Agustín Fernández Cisnal (AF)
Juan Pablo Canepa Leite (JPC)
Giulietta Grigis (G)
Claudio Moretti (C)
Antonio Montefusco (A)
Fabrizio D'Ascenzo (F)
Piera Capasso (P)
Marta Bande (M)
Francesco Casilli (F)
Ramez Morkous (R)
Eric Yang (E)
Harish Ramakrishna (H)
Martin Poloczek (M)
Roman Miklik (R)
Ahmad Al Hallak (A)
Bernardo Cortese (B)
Pilar Jiménez Quevedo (PJ)
Nieves Gonzalo (N)
María Del Trigo (M)
Alfonso de Hoyos Y Fernández de Córdova (A)
Jose Alberto de Agustín (JA)
Armghan Munir (A)
David Vivas (D)

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Iván J Núñez-Gil (IJ)

Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain; Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain. Electronic address: ibnsky@yahoo.es.

Enrico Cerrato (E)

Interventional Cardiology, Infermi Hospital, Rivoli, Turin, Italy.

Mario Bollati (M)

Interventional Cardiology, Policlinico San Donato, Milan, Italy.

Luis Nombela-Franco (L)

Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain.

Belén Terol (B)

Cardiology Department, Hospital Severo Ochoa, Leganés, Spain.

Emilio Alfonso-Rodríguez (E)

Instituto de Cardiología y Cirugía Cardiovascular, La Habana, Cuba.

Santiago J Camacho Freire (SJ)

Interventional Cardiology, Hospital Juan Ramón Jiménez, Huelva, Spain.

Pedro A Villablanca (PA)

Interventional Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA.

Ignacio J Amat Santos (IJ)

CIBERCV, Interventional Cardiology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

José M de la Torre Hernández (JM)

Cardiology Department, Hospital U. Marques de Valdecilla, IDIVAL, Santander, Spain.

Isaac Pascual (I)

Department of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, ISPA, Oviedo, Spain; University of Oviedo, Oviedo, Spain.

Christoph Liebetrau (C)

Kerckhoff Heart and Thorax Center, Department of Cardiology, Bad Nauheim, Germany; DZHK (German Centre for Cardiovascular Research), partner site Rhein-Main, Frankfurt am Main, Germany.

Benjamín Camacho (B)

Interventional Cardiology, Hospital Arnau de Vilanova, Lérida, Spain.

Marco Pavani (M)

Cardiology, Città della Salute e della Scienza, Molinnette II, Torino, Italy.

Juan Albistur (J)

Cardiology, Hospital de Clínicas Dr, Manuel Quintela, Montevideo, Uruguay.

Roberto Adriano Latini (RA)

Cardiologia Interventistica, ASST Fatebenefratelli-Sacco Milan, Italy.

Ferdinando Varbella (F)

Interventional Cardiology, Infermi Hospital, Rivoli, Turin, Italy.

Víctor Alfonso Jiménez-Díaz (VA)

Interventional Cardiology, Hospital Álvaro Cunqueiro, Vigo, Spain.

Davide Piraino (D)

UO di Cardiologia Interventistica ed Emodinamica, Azienda Ospedaliera Universitaria Policlinico "P,Giaccone" Palermo, Italy.

Massimo Mancone (M)

Is Sapienza University of Rome, Policlinico Umberto I. Department of Cardiovascular, Respiratory, Neurological, Anaesthesiology and Geriatric Sciences.

Fernando Alfonso (F)

Cardiology Department, Hospital Universitario de La Princesa, Madrid, Spain.

José Antonio Linares (JA)

Interventional Cardiology, H Lozano Blesa, Zaragoza, Spain.

Ramón Rodríguez-Olivares (R)

Interventional Cardiology, Utrecht Medisch Centrum, Utrecht, the Netherlands.

Jesús M Jiménez Mazuecos (JM)

Interventional Cardiology, H General Universitario de Albacete, Albacete, Spain.

Jorge Palazuelos Molinero (J)

Interventional Cardiology, Hospital central de la Defensa "Gomez Ulla", Madrid, Spain.

Alejandro Sánchez-Grande Flecha (A)

Interventional Cardiology, H Universitario de Canarias, San Cristobal de la Laguna, Spain.

Joan Antoni Gomez-Hospital (JA)

Interventional Cardiology, Hospital de Bellvitge, Barcelona, Spain.

Alfonso Ielasi (A)

Cardiology Division, ASST Bergamo Est, Bolognini Hospital Seriate, Italy.

Íñigo Lozano (Í)

Interventional Cardiology, Hospital de Cabueñes, Gijon, Spain.

Pierluigi Omedè (P)

Cardiology, Città della Salute e della Scienza, Molinnette I, Torino, Italy.

Rodrigo Bagur (R)

Interventional Cardiology, University Hospital, London Health Sciences Centre, London, Ontario, Canada.

Fabrizio Ugo (F)

Interventional Cardiology, H San Giovanni Bosco, Turin, Italy.

Massimo Medda (M)

Interventional Cardiology Unit, Istituto Clinico Sant'Ambrogio, Milan, Italy.

Boshra F Louka (BF)

Division of Cardiovascular Diseases, Mayo Clinic Arizona, USA.

Petr Kala (P)

Department of Internal Medicine and Cardiology, University Hospital Brno and Medical Faculty of Masaryk University, Brno, Czech Republic.

Javier Escaned (J)

Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain; Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Daniel Bautista (D)

Cardiology, Instituto dominicano de Cardiología, Santo Domingo, Dominican Republic.

Gisela Feltes (G)

Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain.

Pablo Salinas (P)

Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain.

Mohamad Alkhouli (M)

Cardiology, West Virginia University Heart and Vascular Institute, Morgantown, WV, United States of America.

Carlos Macaya (C)

Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain; Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

Antonio Fernández-Ortiz (A)

Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain; Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH